Betsi Cadwaladr University Local Health Board ... - Health in Wales

Executive Director of Planning
Executive Director of Finance
Executive Director of Therapies & Health Science
IPC Officer
Associate Director of Performance Improvement and Delivery Support
3.17 The final arrangements for one IPC Panel will be further considered and
detailed in the revised IPC Standard Operating Procedure.
3.18 A panel member must declare an interest if a patient for whom a funding
request is made is known to the panel member.
3.19 The LHB IPC Panel will only consider funding requests that have evidence of
CPG support or those unless subject to appeal. The Panel may take advice in
relation to all requests for treatment from within the relevant CPG, prior to the Panel
making a recommendation.
3.20 The LHB Panel may discuss funding considerations with other LHBs to try and
ensure a consistent approach and the view of any relevant Clinical Networks may be
sought.
3.21 The LHB Panel will review all the information supplied on the agreed
request form and will consider how appropriate the request is based on the
information supplied. The Panel will consider each case on its individual merit and
will base their recommendation on consideration of the facts presented to them in line
with the agreed core principles outlined in Section 2.
3.22 In reaching its recommendation on each individual case, the IPC Panel will
consider:
That all previous relevant criteria have been satisfied (see above)
Whether there is a clear evidence base for clinical outcomes – this will be
established by reference to NICE, Cochrane, Public Health Wales,
AWMSG, SMC and SIGN and other authoritative sources of evidence; by
asking relevant professionals within and outside the LHB and by
consulting with Medical Directors of other LHBs or Public Health Wales.
When an interpretation of evidence is being made, this should be
validated using relevant experts such as LHB Medical Directors, or
relevant health professionals within or outside the LHB.
The effect of the proposed treatment or service on the quality of life, the
social and psychological well being of the patient, symptoms relief and
survival benefit.
Any exceptionality that the individual patient may exhibit.
3.23 This procedure cannot include a complete and exhaustive list of all factors to
be considered, as each case will be considered on a case by case basis, and other
case specific criteria may need to be considered on an individual by individual basis.
12